Home-based care for lung disease in rheumatic conditions
Part of Bones, joints & muscles, Brain & nervous system, Immune system & allergy, Lungs & breathing, Skin clinical trials.
This trial tests whether people with lung disease caused by a rheumatic condition can safely manage their care at home using a smartphone or tablet. It aims to see if home monitoring is as effective as in-person visits for keeping your lungs healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rheumatic disease like systemic sclerosis, rheumatoid arthritis, or a similar condition.
- You have been diagnosed with interstitial lung disease (ILD) on a CT scan at least one year ago.
- Your treatment for ILD or your rheumatic disease has been stable for at least six months.
- You can use a smartphone or tablet with internet access to fill out questionnaires and perform home lung tests.
- You do not have severe heart failure, severe kidney disease, or very advanced lung disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This study helps doctors identify early signs of lung scarring (fibrosis) in patients with autoimmune diseases like scleroderma, rheumatoid arthritis, and Sjögren's syndrome. By catching this early, researchers hope to better understand and treat these complications.
This study tests whether people with systemic sclerosis (scleroderma) and pulmonary arterial hypertension (PAH) can safely monitor their heart health at home using a smartphone or other internet-connected device. If you have PAH and are comfortable using technology, this trial may help make care more convenient.
This trial tests whether a digital self-management program (using a smartphone or tablet) helps people with fibrotic interstitial lung disease better manage their symptoms and quality of life. If you have this lung condition and can use a mobile device, this study could offer you extra support at home.
This study tests whether using a home breathing device, combined with artificial intelligence, can help monitor your lung condition between clinic visits. If it works, it might catch changes early and help you stay healthier.
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
Hear when a new Dermatomyositis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.